Skip to main content
Log in

Low rate of adverse events in a randomized controlled trial addressing the surgical treatment of femoroacetabular impingement (FAI) syndrome

  • HIP
  • Published:
Knee Surgery, Sports Traumatology, Arthroscopy Aims and scope

Abstract

Purpose

The femoroacetabular impingement randomised controlled trial (FIRST) is a multi-center randomized controlled trial (RCT), comparing arthroscopic osteochondroplasty with arthroscopic lavage in adults aged 18–50 years diagnosed with non-arthritic femoroacetabular impingement (FAI) syndrome. The purpose of the present study is to report the prevalence, distribution and severity of adverse events during and within 24-month follow-up period.

Methods

Of the 220 patients included, 6 were adjudicated as ineligible, for a total of 214 patients included in the final analysis. An independent Adjudication Committee evaluated operatively treated and non-operatively treated adverse events that were related to the hip. Adverse events were also reported directly by each participating clinical site. Continuous variables were reported as mean and standard deviation, categorical variables were reported as counts and percentages.

Results

There were a total of 52 (24.2%, 52/214) adverse events in 46 (21.5%) patients (mean age 34.2 ± 7.9 years, 58.7% male) during the 24-month follow-up. There were 12.6% (27/214) operatively treated adverse events for: hip pain, re-injury of labrum and heterotopic ossification. There were 11.7% (25/214) non-operatively treated adverse events for predominantly: hip pain, hip tendinopathy and hip popping/snapping. Approximately, 87% of adverse events resolved within the 24-month follow-up time.

Conclusion

Given the inherent challenges with conducting RCTs, the results of this adverse event study from the FIRST trial demonstrate that it is safe to perform an RCT addressing FAI syndrome.

Level of evidence

Level III.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

DHAR:

Danish Hip Arthroscopic Registry

FAI:

Femoroacetabular impingement

FIRST:

Femoroacetabular impingement randomised controlled trial

FAIT:

Femoroacetabular impingement trial

UK FASHIoN:

Hip arthroscopy versus best conservative care for the treatment of femoroacetabular impingement syndrome

MRI:

Magnetic resonance imaging

RCT:

Randomised control trial

SD:

Standard deviation

US MHS:

US Military Health System

VAS:

Visual Analog Scale

References

  1. Agricola R, Waarsing JH, Arden NK, Carr AJ, Bierma-Zeinstra SM, Thomas GE, Weinans H, Glyn-Jones S (2013) Cam impingement of the hip: a risk factor for hip osteoarthritis. Nat Rev Rheumatol 9(10):630–634

    Article  Google Scholar 

  2. Burman M (1931) Arthroscopy or the direct visualization of joints. J Bone Joint Surg 13:669–694

    Google Scholar 

  3. Investigators F (2015) A multi-centre randomized controlled trial comparing arthroscopic osteochondroplasty and lavage with arthroscopic lavage alone on patient important outcomes and quality of life in the treatment of young adult (18–50) femoroacetabular impingement. BMC Musculoskelet Disord 16:64

    Article  Google Scholar 

  4. First Investigators (2020) Osteochondroplasty and labral repair for the treatment of young adults with femoroacetabular impingement: a randomized controlled trial. Am J Sports Med (in press)

  5. Ganz R, Parvizi J, Beck M, Leunig M, Nötzli H, Siebenrock KA (2003) Femoroacetabular impingement: a cause for osteoarthritis of the hip. Clin Orthop Relat Res 417:112–120

    Google Scholar 

  6. Griffin DR, Dickenson EJ, Wall PDH, Achana F, Donovan JL, Griffin J et al (2018) Hip arthroscopy versus best conservative care for the treatment of femoroacetabular impingement syndrome (UK FASHIoN): a multicentre randomised controlled trial. Lancet 391(10136):2225–2235

    Article  Google Scholar 

  7. Lund B, Mygind-Klavsen B, Gronbech Nielsen T, Maagaard N, Kraemer O, Holmich P et al (2017) Danish hip arthroscopy registry (DHAR): the outcome of patients with femoroacetabular impingement (FAI). J Hip Preserv Surg 4(2):170–177

    Article  Google Scholar 

  8. Mansell NS, Rhon DI, Meyer J, Slevin JM, Marchant BG (2018) Arthroscopic surgery or physical therapy for patients with femoroacetabular impingement syndrome: a randomized controlled trial with 2-year follow-up. Am J Sports Med 46(6):1306–1314

    Article  Google Scholar 

  9. Nakano N, Lisenda L, Jones T, Loveday D, Khanduja V (2017) Complications following arthroscopic surgery of the hip: a systematic review of 36 761 cases. Bone Joint J 99-B(12):1577–1583

    Article  CAS  Google Scholar 

  10. Ohlin A, Karlsson L, Senorski EH, Jonasson P, Ahlden M, Baranto A et al (2019) Quality assessment of prospective cohort studies evaluating arthroscopic treatment for femoroacetabular impingement syndrome: a systematic review. Orthop J Sports Med 7(5):2325967119838533

    Article  Google Scholar 

  11. Palmer AJR, Ayyar Gupta V, Fernquest S, Rombach I, Dutton SJ, Mansour R et al (2019) Arthroscopic hip surgery compared with physiotherapy and activity modification for the treatment of symptomatic femoroacetabular impingement: multicentre randomised controlled trial. BMJ 364:l185

    Article  Google Scholar 

  12. Philippon MJ, Ejnisman L, Ellis HB, Briggs KK (2012) Outcomes 2 to 5 years following hip arthroscopy for femoroacetabular impingement in the patient aged 11 to 16 years. Arthroscopy 28(9):1255–1261

    Article  Google Scholar 

  13. Sampson T (2005) Arthroscopic treatment of femoroacetabular impingement. Tech Orthop 20:56–62

    Article  Google Scholar 

  14. Sansone M, Ahldén M, Jónasson P, Thomeé C, Swärd L, Baranto A et al (2014) A Swedish hip arthroscopy registry: demographics and development. Knee Surg Sports Traumatol Arthrosc 22:774–780

    Article  Google Scholar 

  15. Sansone M, Ahldén M, Jónasson P, Thomeé C, Swärd L, Öhlin A et al (2017) Outcome after hip arthroscopy for femoroacetabular impingement in 289 patients with minimum 2-year follow-up. Scand J Med Sci Sports 27:230–235

    Article  CAS  Google Scholar 

  16. Sardana V, Philippon MJ, de Sa D et al (2015) Revision hip arthroscopy indications and outcomes: a systematic review. Arthroscopy 31(10):2047–2055

    Article  Google Scholar 

  17. Siebenrock KA, Kaschka I, Frauchiger L, Werlen S, Schwab JM (2013) Prevalence of cam-type deformity and hip pain in elite ice hockey players before and after the end of growth. Am J Sports Med 41(10):2308–2313

    Article  Google Scholar 

  18. Sochacki KR, Jack RA 2nd, Safran MR, Nho SJ, Harris JD (2018) There Is a significant discrepancy between “big data” database and original research publications on hip arthroscopy outcomes: a systematic review. Arthroscopy 34(6):1998–2004

    Article  Google Scholar 

  19. Zhan C, Miller M (2003) Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 290(14):1868–1874

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The Collaborating Group is known as the FIRST investigators. This is constituted of the following authors: Steering Committee: Olufemi R. Ayeni (Chair, McMaster University), Mohit Bhandari (Co-Chair, McMaster University), Asheesh Bedi (University of Michigan), Teppo Järvinen (University of Helsinki), Volker Musahl (University of Pittsburgh), Douglas Naudie (University of Western Ontario), Matti Seppänen MD (Turku University), Gerard Slobogean (University of Maryland, Baltimore), Lehana Thabane (McMaster University). Methods Centre: Olufemi R. Ayeni (Principal Investigator); Nicole Simunovic (Research Manager); Andrew Duong, Matthew Skelly, Ajay Shanmugaraj, Sarah Crouch (Project Management); Sheila Sprague (Research Methodologist); Diane Heels-Ansdell, (Statistical Analysis); Lisa Buckingham (Data Management) (McMaster University). Data and Safety Monitoring Committee: Tim Ramsay (Chair, Ottawa Hospital Research Institute), John Lee (University of Toronto), Petteri Kousa (Sports Clinic Hospital Dextra). Adjudication Committee: Sasha Carsen (Chair, University of Ottawa), Hema Choudur (Hamilton Health Sciences), Yan Sim (McMaster University), Kelly Johnston (University of Calgary). Participating Clinical Sites—Canada: McMaster University Medical Centre (Hamilton, ON)—Olufemi R. Ayeni MD, PhD, FRCSC; Sarah Crouch BSc (Pharm); Andrew Duong MSc; Ajay Shanmugaraj BSc; Nicole Simunovic MSc; Matthew Skelly BSc; Sheila Sprague PhD. Dalhousie University (Halifax, NS)—Ivan Wong MD, FRCSC, Dip. Sports Medicine, MACM; Ryland Murphy BSc; Sara Sparavalo MASc. St. Michael’s Hospital (Toronto, ON)—Daniel Whelan MD, MSc, FRCSC; Ryan Khan BA, CCRP. Kingston Health Sciences Centre (Kingston, ON)—Gavin CA Wood MBChB, FRCS; Fiona Howells BPharm; Heather Grant MSc. London Health Sciences Centre (London, ON)—Douglas Naudie MD, MSc, FRCSC; Bryn Zomar MSc; Michael Pollock MSc. Fowler Kennedy Sport Medicine Clinic (London, ON)—Kevin Willits MD, FRCSC; Andrew Firth MSc; Stacey Wanlin; Alliya Remtulla MSc; Nicole Kaniki PhD. CHU de Québec-Université Laval (Quebec City, QC)—Etienne L. Belzile MD; Sylvie Turmel RN. Participating Clinical Sites -International: Odense University Hospital (Odense, Denmark)—Uffe Jørgensen MD, Dr. Med Sci; Annie Gam-Pedersen RN. Tays Hatanpää (Tampere University Hospital, Tampere, Finland)—Raine Sihvonen MD, PhD; Marko Raivio MD; Pirjo Toivonen PT. Turku University Hospital (Turku, Finland)—Matti Seppänen MD; Mari Pirjetta Routapohja RN. Post-trial statement: The Methods Centre at McMaster University coordinated the trial. The Methods Centre was responsible for programming trial randomization, the maintenance of the database, data validation, data analyses, and study-centre coordination. The Steering Committee designed the trial, some members assisted with developing the statistical analysis plan, and vouch for the completeness and accuracy of the data and analyses.

Funding

Research grants were received from the Canadian Institutes of Health Research (CIHR) (PI: OR Ayeni and M Bhandari), American Orthopaedic Society for Sports Medicine (PI: OR Ayeni), Canadian Orthopaedic Foundation (PI: OR Ayeni and M Bhandari), McMaster Surgical Associates (PI: OR Ayeni and M Bhandari), and Hamilton Health Sciences Department of Surgery (PI: OR Ayeni). Dr. M Bhandari was also funded, in part, by a Canada research chair in musculoskeletal trauma, which is unrelated to the present study (McMaster University, Hamilton, ON, Canada).

Author information

Authors and Affiliations

Authors

Consortia

Contributions

The manuscript was conducted and drafted by AO, NS, AD and ORA. The FIRST investigators conducted the research study, and were responsible for the recruitment and follow-up of all patients. All authors have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data, have been involved in drafting the manuscript and revising it critically for important intellectual content, have given final approval of the version to be published, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Olufemi R. Ayeni.

Ethics declarations

Conflict of interest

The authors declared that they have no conflict of interest.

Ethical approval

Ethics approval was granted by the Hamilton Integrated Research Ethics Board #12-396.

Informed consent

Informed consent was provided by all patients in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ohlin, A., Simunovic, N., Duong, A. et al. Low rate of adverse events in a randomized controlled trial addressing the surgical treatment of femoroacetabular impingement (FAI) syndrome. Knee Surg Sports Traumatol Arthrosc 29, 2015–2020 (2021). https://doi.org/10.1007/s00167-020-06236-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00167-020-06236-6

Keywords

Navigation